España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Illumina
ILMN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$132.74
-0.27
-0.20%
At close: -
$130.00
-2.74
-2.06%
After Hours: Jan 31, 6:34 PM EDT
Get Report
Comment
Q4 2024 Earnings in 5 days from now on Thu Feb 6th, after the market close
Conference call scheduled in 5 days at 16:30 PM
Click to view the webcast
Illumina (ILMN) Forecast
News
Earnings
Illumina (ILMN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Illumina (NASDAQ:ILMN) Stock
Illumina Stock (NASDAQ: ILMN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 30, 2025
How Is The Market Feeling About Illumina?
Benzinga Insights
Monday, January 27, 2025
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Benzinga Insights
Wednesday, January 22, 2025
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies
Rounak Jain
Tuesday, January 14, 2025
Illumina Raises Q4 Revenue Outlook To $1.10 Billion, Exceeding Street Expectations; Sees Solid Margins
Nabaparna Bhattacharya
Illumina shares are trading lower after the c...
Benzinga Newsdesk
Illumina Announces Preliminary Financials For...
Benzinga Newsdesk
Nvidia Eyes $1 Billion In Healthcare AI Revenue: Is This The Next Growth Frontier?
Surbhi Jain
Monday, January 13, 2025
Morgan Stanley Maintains Equal-Weight on Illu...
Benzinga Newsdesk
Illumina, NVIDIA To Collaborate To 'Decode Bi...
Benzinga Newsdesk
Illumina Launches Proteomics Pilot with 50,00...
Benzinga Newsdesk
Saturday, January 11, 2025
Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce
Rounak Jain
Tuesday, January 07, 2025
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Benzinga Insights
Illumina Announces NovaSeq X Updates With Sin...
Benzinga Newsdesk
Wednesday, December 25, 2024
How Is The Market Feeling About Illumina?
Benzinga Insights
Tuesday, December 24, 2024
Santa Claus Rally: 10 S&P 500 Stocks That Consistently Outperform During Year-End Optimism
Piero Cingari
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Benzinga Insights
Friday, December 20, 2024
Traders Fight The Grinch To Save The Santa Rally: 10 S&P 500 Stocks Poised For A Year-End Surge
Piero Cingari
Monday, December 16, 2024
Super Micro Drops Below 50-Day Average, Faces Nasdaq 100 Removal Just Months After Entry
Anusuya Lahiri
What's Going On With Illumina Stock On Monday?
Vandana Singh
What's Going On With Super Micro Computer Shares Monday?
Dylan Berman
US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'
Rishabh Mishra
Saturday, December 14, 2024
MicroStrategy, Palantir, Axon Added To Nasdaq 100: Super Micro Computer, Moderna, Illumina Exit The Index
Rounak Jain
Wednesday, December 11, 2024
This D.R. Horton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Avi Kapoor
Citigroup Downgrades Illumina to Neutral, Low...
Benzinga Newsdesk
Wednesday, December 04, 2024
Synaffix Entered Into A Licensing Agreement W...
Benzinga Newsdesk
Wednesday, November 20, 2024
Myriad Genetics Announces The Incorporation O...
Benzinga Newsdesk
Tuesday, November 19, 2024
Illumina Highlights TruSight Oncology Portfol...
Benzinga Newsdesk
Tuesday, November 12, 2024
Morgan Stanley Reinstates Equal-Weight on Ill...
Benzinga Newsdesk
Stephens & Co. Maintains Overweight on Illumi...
Benzinga Newsdesk
Monday, November 11, 2024
Piper Sandler Maintains Overweight on Illumin...
Benzinga Newsdesk
Wednesday, November 06, 2024
Baird Maintains Neutral on Illumina, Raises P...
Benzinga Newsdesk
Tuesday, November 05, 2024
TD Cowen Maintains Buy on Illumina, Raises Pr...
Benzinga Newsdesk
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
Piero Cingari
UBS Maintains Neutral on Illumina, Raises Pri...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Illumina,...
Benzinga Newsdesk
JP Morgan Maintains Neutral on Illumina, Rais...
Benzinga Newsdesk
Citigroup Maintains Buy on Illumina, Raises P...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on Illumina, ...
Benzinga Newsdesk
Canaccord Genuity Maintains Hold on Illumina,...
Benzinga Newsdesk
Monday, November 04, 2024
Illumina Raises FY2024 Adj EPS Guidance from ...
Benzinga Newsdesk
Illumina Sees Q4 Sales $1.070B vs $1.08B Est
Benzinga Newsdesk
Illumina Q3 2024 Adj. EPS $1.14 Beats $0.88 E...
Benzinga Newsdesk
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
Piero Cingari
Looking Into Illumina's Recent Short Interest
Benzinga Insights
Thursday, October 31, 2024
Illumina Announces That It Will Present Updat...
Benzinga Newsdesk
Monday, October 28, 2024
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,600 Today
Benzinga Insights
Thursday, October 17, 2024
Leerink Partners Maintains Outperform on Illu...
Benzinga Newsdesk
This Illumina Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Avi Kapoor
HSBC Upgrades Illumina to Buy, Announces $180...
Benzinga Newsdesk
Wednesday, October 16, 2024
$100 Invested In This Stock 20 Years Ago Would Be Worth $4,600 Today
Benzinga Insights
Show More